Michael Barbella, Managing Editor01.25.23
ZetrOZ Systems has introduced its newest innovation, the sam x1, a device for delivering high-quality, effective soft tissue and injury healing capabilities at home.
"We intentionally and thoughtfully designed the sam x1 with ergonomics in mind to deliver the same soft tissue healing for pain and injury in wireless form," ZetrOZ Systems Founder/CEO Dr. George Lewis said. "The sam x1 is poised to make a difference in the lives of hundreds of thousands of patients dealing with soft tissue injuries."
Designed for ergonomics and ultrasound delivery to increase circulation and promote soft tissue healing, sam x1 delivers 33 times more energy than a bone-growth stimulator after just one hour of treatment. Additional research shows:
The sam gel capture patch creates the ideal connection and fit for healing. The wireless capability allows sam® to attach securely and discreetly, balancing for weight but allowing patients to participate in aggressive activity. A rugged storage case, including two rapid chargers, a quick start guide, and a user manual, offers on-the-go usage.
"Backed by thousands of successful patient outcomes, sam x1 is shifting the paradigm in the care of soft tissue injuries, and we are excited to see doctors and physicians utilize this treatment to better the lives of their patients," Lewis said.
After more than a decade of development, sam x1 is the first wireless long-duration ultrasound system that is cleared by the U.S. Food and Drug Administration for prescription home use. sam x1 is made in the United States and covered by 48 patents.
ZetrOZ Systems develops wearable bioelectronic devices for delivering sustained acoustic medicine (sam). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of 48 patents and is the exclusive manufacturer and developer of sam, a product line designed for the treatment of acute and chronic musculoskeletal conditions.
"We intentionally and thoughtfully designed the sam x1 with ergonomics in mind to deliver the same soft tissue healing for pain and injury in wireless form," ZetrOZ Systems Founder/CEO Dr. George Lewis said. "The sam x1 is poised to make a difference in the lives of hundreds of thousands of patients dealing with soft tissue injuries."
Designed for ergonomics and ultrasound delivery to increase circulation and promote soft tissue healing, sam x1 delivers 33 times more energy than a bone-growth stimulator after just one hour of treatment. Additional research shows:
- Medical staff have 87% satisfaction and increased confidence in sam to accelerate the healing process from overuse injuries (Draper et al., 2021)
- sam treatment provides tissue healing and recovery, improved patient function, and reduced pain. When patients failed to respond to physical therapy, sam proved to be a useful adjunct to facilitate healing and return to work (Winkler et al., 2021)
- sam provided clinical patient improvement in under two weeks of treatment and a 50% reduction of pain medication (Walters et al., 2022, clinical presentation)
- Roughly 87.3% of athletes are highly receptive to treatment and have a high level of confidence for improved function and return to work after 30 days of sam use (Walters et al., 2022, clinical presentation)
The sam gel capture patch creates the ideal connection and fit for healing. The wireless capability allows sam® to attach securely and discreetly, balancing for weight but allowing patients to participate in aggressive activity. A rugged storage case, including two rapid chargers, a quick start guide, and a user manual, offers on-the-go usage.
"Backed by thousands of successful patient outcomes, sam x1 is shifting the paradigm in the care of soft tissue injuries, and we are excited to see doctors and physicians utilize this treatment to better the lives of their patients," Lewis said.
After more than a decade of development, sam x1 is the first wireless long-duration ultrasound system that is cleared by the U.S. Food and Drug Administration for prescription home use. sam x1 is made in the United States and covered by 48 patents.
ZetrOZ Systems develops wearable bioelectronic devices for delivering sustained acoustic medicine (sam). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of 48 patents and is the exclusive manufacturer and developer of sam, a product line designed for the treatment of acute and chronic musculoskeletal conditions.